FABBRI, CHIARA
FABBRI, CHIARA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Ricercatori a tempo determinato
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders
2018 Fabbri, Chiara; Serretti, Alessandro
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
2022 Fanelli, Giuseppe; Domschke, Katharina; Minelli, Alessandra; Gennarelli, Massimo; Martini, Paolo; Bortolomasi, Marco; Maron, Eduard; Squassina, Alessio; Kasper, Siegfried; Zohar, Joseph; Souery, Daniel; Montgomery, Stuart; Albani, Diego; Forloni, Gianluigi; Ferentinos, Panagiotis; Rujescu, Dan; Mendlewicz, Julien; De Ronchi, Diana; Baune, Bernhard T; Serretti, Alessandro; Fabbri, Chiara
A model to investigate SNPs' interaction in GWAS studies
2015 Cocchi, Enrico; Drago, Antonio; Fabbri, Chiara; Serretti, Alessandro
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
2020 Fabbri C.; Kasper S.; Kautzky A.; Zohar J.; Souery D.; Montgomery S.; Albani D.; Forloni G.; Ferentinos P.; Rujescu D.; Mendlewicz J.; Uher R.; Lewis C.M.; Serretti A.
Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study
2020 Dold M.; Bartova L.; Fugger G.; Mitschek M.M.M.; Kautzky A.; Frey R.; Montgomery S.; Zohar J.; Mendlewicz J.; Souery D.; Fabbri C.; Serretti A.; Kasper S.
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors
2016 Mandelli, Laura; Toscano, Elena; Porcelli, Stefano; Fabbri, Chiara; Serretti, Alessandro
An interview with Dr Chiara Fabbri: pharmacogenomics and drug repurposing for treatment-resistant depression
2021 Fabbri, Chiara
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial
2015 Takekita, Yoshiteru; Fabbri, Chiara; Kato, Masaki; Nonen, Shinpei; Sakai, Shiho; Sunada, Naotaka; Koshikawa, Yosuke; Wakeno, Masataka; Okugawa, Gaku; Kinoshita, Toshihiko; Serretti, Alessandro
Anxiety disorders and age-related changes in physiology
2022 Mutz, Julian; Hoppen, Thole H; Fabbri, Chiara; Lewis, Cathryn M
Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder
2020 Mosheva M.; Serretti A.; Stukalin Y.; Fabbri C.; Hagin M.; Horev S.; Mantovani V.; Bin S.; Mattiaccio A.; Nivoli A.; Vieta E.; Popovic D.
Cariprazine specificity profile in the treatment of acute schizophrenia: A meta-Analysis and meta-regression of randomized-controlled trials
2017 Corponi, Filippo; Serretti, Alessandro; Montgomery, Stuart; Fabbri, Chiara
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study
2015 Probst-Schendzielorz, Kristina; Scholl, Catharina; Efimkina, Olga; Ersfeld, Eva; Viviani, Roberto; Serretti, Alessandro; Fabbri, Chiara; Gurwitz, David; Lucae, Susanne; Ising, Marcus; Paul, Anna Maria; Lehmann, Marie-Louise; Steffens, Michael; Crisafulli, Concetta; Calabrò, Marco; Holsboer, Florian; Stingl, Julia
Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies
2020 Fabbri C.; Serretti A.
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
2020 Fugger G.; Dold M.; Bartova L.; Mitschek M.M.M.; Souery D.; Mendlewicz J.; Serretti A.; Zohar J.; Montgomery S.; Fabbri C.; Frey R.; Kasper S.
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
2019 Kautzky A.; Dold M.; Bartova L.; Spies M.; Kranz G.S.; Souery D.; Montgomery S.; Mendlewicz J.; Zohar J.; Fabbri C.; Serretti A.; Lanzenberger R.; Dikeos D.; Rujescu D.; Kasper S.
Clinical features and drug induced side effects in early versus late antidepressant responders.
2013 Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A.
Clinical, demographic, and genetic risk factors of treatment-attributed suicidality in >10,000 Australian adults taking antidepressants
2022 Campos, Adrian I; Byrne, Enda M; Iorfino, Frank; Fabbri, Chiara; Hickie, Ian B; Lewis, Cathryn M; Wray, Naomi R; Medland, Sarah E; Rentería, Miguel E; Martin, Nicholas G
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial
2016 Takekita, Yoshiteru; Koshikawa, Yosuke; Fabbri, Chiara; Sakai, Shiho; Sunada, Naotaka; Onohara, Ai; Nishida, Keiichiro; Yoshimura, Masafumi; Kato, Masaki; Serretti, Alessandro; Kinoshita, Toshihiko
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression
2021 Bartova L.; Fugger G.; Dold M.; Swoboda M.M.M.; Zohar J.; Mendlewicz J.; Souery D.; Montgomery S.; Fabbri C.; Serretti A.; Kasper S.
Comparison of Mortality Rates between Italian and Foreign-born Patients with Alcohol Use Disorders
2021 Pavarin R.M.; Fioritti A.; Fabbri C.; Sanchini S.; De Ronchi D.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders | Fabbri, Chiara; Serretti, Alessandro | 2018-01-01 | THE LANCET. PSYCHIATRY | - | 1.01 Articolo in rivista | - |
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response | Fanelli, Giuseppe; Domschke, Katharina; Minelli, Alessandra; Gennarelli, Massimo; Martini, Paolo;... Bortolomasi, Marco; Maron, Eduard; Squassina, Alessio; Kasper, Siegfried; Zohar, Joseph; Souery, Daniel; Montgomery, Stuart; Albani, Diego; Forloni, Gianluigi; Ferentinos, Panagiotis; Rujescu, Dan; Mendlewicz, Julien; De Ronchi, Diana; Baune, Bernhard T; Serretti, Alessandro; Fabbri, Chiara | 2022-01-01 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
A model to investigate SNPs' interaction in GWAS studies | Cocchi, Enrico; Drago, Antonio; Fabbri, Chiara; Serretti, Alessandro | 2015-01-01 | JOURNAL OF NEURAL TRANSMISSION | - | 1.01 Articolo in rivista | - |
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping | Fabbri C.; Kasper S.; Kautzky A.; Zohar J.; Souery D.; Montgomery S.; Albani D.; Forloni G.; Fere...ntinos P.; Rujescu D.; Mendlewicz J.; Uher R.; Lewis C.M.; Serretti A. | 2020-01-01 | TRANSLATIONAL PSYCHIATRY | - | 1.01 Articolo in rivista | s41398-020-0738-5.pdf |
Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study | Dold M.; Bartova L.; Fugger G.; Mitschek M.M.M.; Kautzky A.; Frey R.; Montgomery S.; Zohar J.; Me...ndlewicz J.; Souery D.; Fabbri C.; Serretti A.; Kasper S. | 2020-01-01 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors | Mandelli, Laura; Toscano, Elena; Porcelli, Stefano; Fabbri, Chiara; Serretti, Alessandro | 2016-01-01 | PSYCHIATRY INVESTIGATION | - | 1.01 Articolo in rivista | - |
An interview with Dr Chiara Fabbri: pharmacogenomics and drug repurposing for treatment-resistant depression | Fabbri, Chiara | 2021-01-01 | PHARMACOGENOMICS | - | 1.04 Replica / breve intervento (e simili) | - |
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial | Takekita, Yoshiteru; Fabbri, Chiara; Kato, Masaki; Nonen, Shinpei; Sakai, Shiho; Sunada, Naotaka;... Koshikawa, Yosuke; Wakeno, Masataka; Okugawa, Gaku; Kinoshita, Toshihiko; Serretti, Alessandro | 2015-01-01 | EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | - |
Anxiety disorders and age-related changes in physiology | Mutz, Julian; Hoppen, Thole H; Fabbri, Chiara; Lewis, Cathryn M | 2022-01-01 | THE BRITISH JOURNAL OF PSYCHIATRY | - | 1.01 Articolo in rivista | Mutz_anx_ageBrJP22.pdf |
Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder | Mosheva M.; Serretti A.; Stukalin Y.; Fabbri C.; Hagin M.; Horev S.; Mantovani V.; Bin S.; Mattia...ccio A.; Nivoli A.; Vieta E.; Popovic D. | 2020-01-01 | JOURNAL OF AFFECTIVE DISORDERS | - | 1.01 Articolo in rivista | - |
Cariprazine specificity profile in the treatment of acute schizophrenia: A meta-Analysis and meta-regression of randomized-controlled trials | Corponi, Filippo; Serretti, Alessandro; Montgomery, Stuart; Fabbri, Chiara | 2017-01-01 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study | Probst-Schendzielorz, Kristina; Scholl, Catharina; Efimkina, Olga; Ersfeld, Eva; Viviani, Roberto...; Serretti, Alessandro; Fabbri, Chiara; Gurwitz, David; Lucae, Susanne; Ising, Marcus; Paul, Anna Maria; Lehmann, Marie-Louise; Steffens, Michael; Crisafulli, Concetta; Calabrò, Marco; Holsboer, Florian; Stingl, Julia | 2015-01-01 | PHARMACOGENOMICS | - | 1.01 Articolo in rivista | - |
Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies | Fabbri C.; Serretti A. | 2020-01-01 | NEUROSCIENCE LETTERS | - | 1.01 Articolo in rivista | - |
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression | Fugger G.; Dold M.; Bartova L.; Mitschek M.M.M.; Souery D.; Mendlewicz J.; Serretti A.; Zohar J.;... Montgomery S.; Fabbri C.; Frey R.; Kasper S. | 2020-01-01 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | pyaa035.pdf |
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study | Kautzky A.; Dold M.; Bartova L.; Spies M.; Kranz G.S.; Souery D.; Montgomery S.; Mendlewicz J.; Z...ohar J.; Fabbri C.; Serretti A.; Lanzenberger R.; Dikeos D.; Rujescu D.; Kasper S. | 2019-01-01 | ACTA PSYCHIATRICA SCANDINAVICA | - | 1.01 Articolo in rivista | acps.12959.pdf; acps12959-sup-0001-supinfo.docx |
Clinical features and drug induced side effects in early versus late antidepressant responders. | Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A. | 2013-01-01 | JOURNAL OF PSYCHIATRIC RESEARCH | - | 1.01 Articolo in rivista | - |
Clinical, demographic, and genetic risk factors of treatment-attributed suicidality in >10,000 Australian adults taking antidepressants | Campos, Adrian I; Byrne, Enda M; Iorfino, Frank; Fabbri, Chiara; Hickie, Ian B; Lewis, Cathryn M;... Wray, Naomi R; Medland, Sarah E; Rentería, Miguel E; Martin, Nicholas G | 2022-01-01 | AMERICAN JOURNAL OF MEDICAL GENETICS. PART B, NEUROPSYCHIATRIC GENETICS | - | 1.01 Articolo in rivista | Campos_suicide_AJMG_22.pdf; AJMG-189-196-s001.docx |
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial | Takekita, Yoshiteru; Koshikawa, Yosuke; Fabbri, Chiara; Sakai, Shiho; Sunada, Naotaka; Onohara, A...i; Nishida, Keiichiro; Yoshimura, Masafumi; Kato, Masaki; Serretti, Alessandro; Kinoshita, Toshihiko | 2016-01-01 | BMC PSYCHIATRY | - | 1.01 Articolo in rivista | s12888-016-0883-9.pdf |
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression | Bartova L.; Fugger G.; Dold M.; Swoboda M.M.M.; Zohar J.; Mendlewicz J.; Souery D.; Montgomery S....; Fabbri C.; Serretti A.; Kasper S. | 2021-01-01 | JOURNAL OF PSYCHIATRIC RESEARCH | - | 1.01 Articolo in rivista | 1-s2.0-S0022395621004027-main.pdf; 1-s2.0-S0022395621004027-mmc1.docx |
Comparison of Mortality Rates between Italian and Foreign-born Patients with Alcohol Use Disorders | Pavarin R.M.; Fioritti A.; Fabbri C.; Sanchini S.; De Ronchi D. | 2021-01-01 | JOURNAL OF PSYCHOACTIVE DRUGS | - | 1.01 Articolo in rivista | - |